Selected Key Figures

  • Sales

    Key figure Sales (bar chart)Key figure Sales (bar chart) Inactive key figure Sales (bar chart)Inactive key figure Sales (bar chart)
  • EBITDA Before Special Items

    Key figure EBITDA margin (bar chart)Key figure EBITDA margin (bar chart) Inactive key figure EBITDA margin (bar chart)Inactive key figure EBITDA margin (bar chart)
  • Net income

    Inactive key figure Net income (bar chart)Inactive key figure Net income (bar chart) Key figure Net income (bar chart)Key figure Net income (bar chart)


Sales of the Bayer Group increased by 2.3 percent to €11,833 million in the second quarter of 2016 after adjusting for currency and portfolio changes (reported: – 1.4 percent).

View all Q2 key figures


Despite negative currency effects of €90 million, dissynergies from the Covestro IPO and the divestiture of Diabetes Care, Group EBITDA before special items improved by 5.7 percent to €3,054 million.

View all Q2 key figures


After income tax expense of €431 million, income from discontinued operations after income taxes and noncontrolling interest, net income in the second quarter of 2016 came to €1,380 million (Q2 2015: €1,164 million).

View all Q2 key figures

Business Development of the Divisions


Sales of Pharmaceuticals rose by an encouraging 8.4 percent currency and portfolio adjusted to €4,104 million in the second quarter of 2016. Our recently launched products continued their strong development.

Find out more

Consumer Health

Sales of Consumer Health rose by 4.0 percent currency and portfolio adjusted in the second quarter of 2016 to €1,553 million. Our Claritin™, Aspirin™, Bepanthen™ / Bepanthol™ and Canesten™ brands posted very high growth rates

Find out more

Crop Science

In the second quarter of 2016, Crop Science posted sales of €2,518 million (currency and portfolio adjusted + 0.4 percent). Business at Crop Protection / Seeds was steady year on year despite an ongoing weak market environment. Environmental Science posted a slight decline in sales.

Find out more